Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Neuphoria Therapeutics Inc. (NEUP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Neuphoria Therapeutics Inc. (NEUP), most recent 12 months reported: revenue $1.17M, net loss $13.45M. Latest balance sheet on file: liquid cash $19.87M. From SEC filings. Others in Pharmaceutical Preparations: Cartesian Therapeutics, Inc. · AVENUE THERAPEUTICS, INC. · Dare Bioscience, Inc. · LONGEVERON INC. · China SXT Pharmaceuticals, Inc. · 60 DEGREES PHARMACEUTICALS, INC. · Shattuck Labs, Inc. · RAFAEL HOLDINGS, INC.

Stock screener

Watchlist